Prediction of MiRNA‑mRNA Network Regulating the Migration Ability of Cytarabine‑resistant HL60 Cells

Overview

Journal Biomed Rep

Specialty Biochemistry

Date 2024 Jan 3

PMID 38170076

Authors

Wan-Yi Hsu

Shyh-Shin Chiou

Pei-Chin Lin

Yu-Mei Liao

Chung-Yu Yeh

Yu-Hsin Tseng

Affiliations

Soon will be listed here.

Abstract

Cytarabine is an important medicine for acute myeloid leukemia (AML) treatment, however, drug resistance hinders the treatment of AML. Although microRNA (miRNA or miR) alteration is one of the well-recognized mechanisms underlying drug resistance in AML, few studies have investigated the role and function of miRNAs in the development of cytarabine resistance. In the present study, total RNA was isolated from parental HL60 and cytarabine-resistant HL60 (R-HL60) cells. Subsequently, miRNAs and mRNAs were detected using small RNA sequencing and gene expression array, respectively. Differentially expressed mRNAs (DEMs) and differentially expressed genes (DEGs) with more than two-fold changes between HL60 and R-HL60 cells were screened out. Negatively associated miRNA-mRNA pairs were selected as candidate miRNA-mRNA target pairs according to the miRDB, Targetscan or miRTar databases. Functional enrichment analysis of DEGs included in the candidate miRNA-mRNA pairs was performed. The results indicated that 10 DEGs (, , , , , , , , and were simultaneously involved in seven Gene Ontology pathways related to the regulation of migration ability, namely the 'regulation of cell migration', 'regulation of locomotion', 'regulation of cellular component movement', 'cell migration', 'locomotion', 'cell motility', and 'localization of cell'. DEMs predicted to negatively regulate the aforementioned 10 DEGs were paired with DEGs into 16 candidate miRNA-mRNA pairs related to the regulation of migration ability. In addition, migration assays revealed that the migration ability of R-HL60 cells was greater than that of HL60 cells. These findings provide a new perspective for the treatment of cytarabine-resistant AML and advance our understanding of altered migration ability underlying cytarabine resistance development, specifically related to miRNAs.

References

Guo J, Zhou X, Cheng L, Gao X . Construction of a miRNA-mRNA network related to exosomes in metastatic hepatocellular carcinoma. Heliyon. 2023; 9(4):e15428. PMC: 10123261. DOI: 10.1016/j.heliyon.2023.e15428. View

Xu M, Sun J, Yu Y, Pang Q, Lin X, Barakat M . TM4SF1 involves in miR-1-3p/miR-214-5p-mediated inhibition of the migration and proliferation in keloid by regulating AKT/ERK signaling. Life Sci. 2020; 254:117746. DOI: 10.1016/j.lfs.2020.117746. View

Liu Y, Cheng Z, Pang Y, Cui L, Qian T, Quan L . Role of microRNAs, circRNAs and long noncoding RNAs in acute myeloid leukemia. J Hematol Oncol. 2019; 12(1):51. PMC: 6534901. DOI: 10.1186/s13045-019-0734-5. View

Bhise N, Chauhan L, Shin M, Cao X, Pounds S, Lamba V . MicroRNA-mRNA Pairs Associated with Outcome in AML: From In Vitro Cell-Based Studies to AML Patients. Front Pharmacol. 2016; 6:324. PMC: 4729948. DOI: 10.3389/fphar.2015.00324. View

Chou C, Shrestha S, Yang C, Chang N, Lin Y, Liao K . miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions. Nucleic Acids Res. 2017; 46(D1):D296-D302. PMC: 5753222. DOI: 10.1093/nar/gkx1067. View

Yu D, Song X, Yan C . Oncogenic miRNA-1908 targets HDAC10 and promotes the aggressive phenotype of cervical cancer cell. Kaohsiung J Med Sci. 2021; 37(5):402-410. DOI: 10.1002/kjm2.12348. View

Garcia D, Baek D, Shin C, Bell G, Grimson A, Bartel D . Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs. Nat Struct Mol Biol. 2011; 18(10):1139-46. PMC: 3190056. DOI: 10.1038/nsmb.2115. View

Szklarczyk D, Gable A, Lyon D, Junge A, Wyder S, Huerta-Cepas J . STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2018; 47(D1):D607-D613. PMC: 6323986. DOI: 10.1093/nar/gky1131. View

Whiteley A, Price T, Cantelli G, Sipkins D . Leukaemia: a model metastatic disease. Nat Rev Cancer. 2021; 21(7):461-475. PMC: 8722462. DOI: 10.1038/s41568-021-00355-z. View

10.

Morimatsu M, Yamashita E, Seno S, Sudo T, Kikuta J, Mizuno H . Migration arrest of chemoresistant leukemia cells mediated by MRTF-SRF pathway. Inflamm Regen. 2020; 40:15. PMC: 7336645. DOI: 10.1186/s41232-020-00127-6. View

11.

Zhang H, Zhang Z, Gao L, Qiao Z, Yu M, Yu B . miR-1-3p suppresses proliferation of hepatocellular carcinoma through targeting SOX9. Onco Targets Ther. 2019; 12:2149-2157. PMC: 6434909. DOI: 10.2147/OTT.S197326. View

12.

Sathyanarayanan A, Chandrasekaran K, Karunagaran D . microRNA-146a inhibits proliferation, migration and invasion of human cervical and colorectal cancer cells. Biochem Biophys Res Commun. 2016; 480(4):528-533. DOI: 10.1016/j.bbrc.2016.10.054. View

13.

Liu X, Liao W, Peng H, Luo X, Luo Z, Jiang H . miR-181a promotes G1/S transition and cell proliferation in pediatric acute myeloid leukemia by targeting ATM. J Cancer Res Clin Oncol. 2015; 142(1):77-87. DOI: 10.1007/s00432-015-1995-1. View

14.

Yang Y, Yang H, Lian X, Yang S, Shen H, Wu S . Circulating microRNA: Myocardium-derived prenatal biomarker of ventricular septal defects. Front Genet. 2022; 13:899034. PMC: 9403759. DOI: 10.3389/fgene.2022.899034. View

15.

Gabra M, Salmena L . microRNAs and Acute Myeloid Leukemia Chemoresistance: A Mechanistic Overview. Front Oncol. 2017; 7:255. PMC: 5674931. DOI: 10.3389/fonc.2017.00255. View

16.

Trino S, Lamorte D, Caivano A, Laurenzana I, Tagliaferri D, Falco G . MicroRNAs as New Biomarkers for Diagnosis and Prognosis, and as Potential Therapeutic Targets in Acute Myeloid Leukemia. Int J Mol Sci. 2018; 19(2). PMC: 5855682. DOI: 10.3390/ijms19020460. View

17.

Tseng Y, Yang R, Chiou S, Shieh T, Shih Y, Lin P . Curcumin induces apoptosis by inhibiting BCAT1 expression and mTOR signaling in cytarabine‑resistant myeloid leukemia cells. Mol Med Rep. 2021; 24(2). PMC: 8201441. DOI: 10.3892/mmr.2021.12204. View

18.

Farge T, Saland E, De Toni F, Aroua N, Hosseini M, Perry R . Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism. Cancer Discov. 2017; 7(7):716-735. PMC: 5501738. DOI: 10.1158/2159-8290.CD-16-0441. View

19.

Zhang Y, Ruan F . LncRNA LEF1-AS1 Promotes Ovarian Cancer Development Through Interacting with miR-1285-3p. Cancer Manag Res. 2020; 12:687-694. PMC: 6997035. DOI: 10.2147/CMAR.S227652. View

20.

Wang S, Shih Y, Shieh T, Tseng Y . Proteasome Inhibitors Interrupt the Activation of Non-Canonical NF-κB Signaling Pathway and Induce Cell Apoptosis in Cytarabine-Resistant HL60 Cells. Int J Mol Sci. 2022; 23(1). PMC: 8745175. DOI: 10.3390/ijms23010361. View